Bortezomib for induction therapy in multiple myeloma before high-dose chemotherapy and autologous stem cell transplantation: Multiple myeloma - bortezomib (induction therapy): evaluation report
Cited by National Institute for Health and Care Excellence on
The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.